Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002472 · ClinicalTrials.gov registry record · Phase 2
Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002472: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00002472 is a Phase 2 study that has completed, run by Mayo Clinic. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002472, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of cisplatin and etoposide in treating patients with CNS tumors.
Interventions
- DRUG cisplatin
- DRUG etoposide
- PROCEDURE conventional surgery
- RADIATION radiation therapy
- PROCEDURE neoadjuvant therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1991-03 |
| Est. Completion | 2005-08 |
| Phase | Phase 2 |
What the finished NCT00002472 record still lists
NCT00002472 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00002472 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002472 about?
NCT00002472 is a clinical study titled "Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of cisplatin and etoposide in treating patients with CNS tumors.
What is the current status of trial NCT00002472?
This trial is currently completed. It is a Phase 2 study. The study started on 1991-03. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00002472?
The interventions under investigation include: cisplatin (DRUG), etoposide (DRUG), conventional surgery (PROCEDURE), radiation therapy (RADIATION), neoadjuvant therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00002472?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia